APA (7th ed.) Citation

Gu, S. L., Nath, S., & Markova, A. (2023). Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events. Pharmaceuticals (14248247), 16(11), 1610. https://doi.org/10.3390/ph16111610

Chicago Style (17th ed.) Citation

Gu, Stephanie L., Sandy Nath, and Alina Markova. "Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events." Pharmaceuticals (14248247) 16, no. 11 (2023): 1610. https://doi.org/10.3390/ph16111610.

MLA (9th ed.) Citation

Gu, Stephanie L., et al. "Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events." Pharmaceuticals (14248247), vol. 16, no. 11, 2023, p. 1610, https://doi.org/10.3390/ph16111610.